GLP-1 receptor agonists and cardiovascular outcomes in patients with type 2 diabetes: Clinical evidence and best practice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

GLP-1 receptor agonists and cardiovascular outcomes in patients with type 2 diabetes: Clinical evidence and best practice

Published:2022-02 Issue:2 Volume:34 Page:418-440
ISSN:2327-6924
Container-title:Journal of the American Association of Nurse Practitioners
language:en
Short-container-title:J Am Assoc Nurse Pract

Author:

Coke Lola A.,Deedwania Prakash C.,Hinnen Debbie,Magwire Melissa,Miller Nancy H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Nursing

Reference87 articles.

1. A meta-analysis comparing clinical effects of short- or long-acting GLP-1RAs versus insulin treatment from head-to-head studies in type 2 diabetic patients;Abd El Aziz;Diabetes, Obesity & Metabolism,2017

2. Effects of intensive glucose lowering in type 2 diabetes;Gerstein;The New England Journal of Medicine,2008

3. Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes;Gerstein;Diabetes Care,2016

4. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes;Patel;The New England Journal of Medicine,2008

5. Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): A 56-week, open-label, randomized clinical trial;Ahmann;Diabetes Care,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, pharmacokinetics, and pharmacodynamics of TG103, a novel long-acting GLP-1/Fc fusion protein after a single ascending dose in Chinese healthy subjects;European Journal of Pharmaceutical Sciences;2023-06

2. Effect of 5:2 Fasting Diet on Liver Fat Content in Patients with Type 2 Diabetic with Nonalcoholic Fatty Liver Disease;Metabolic Syndrome and Related Disorders;2022-10-01

3. Type 2 Diabetes and Oxidative Stress and Inflammation: Pathophysiological Mechanisms and Possible Therapeutic Options;Antioxidants;2022-05-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3